| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Sonal Singh, Noelle M Cocoros, Xiaojuan Li, Kathleen M Mazor, Mary T Antonelli, Lauren Parlett, Mark Paullin, Thomas P Harkins, Yunping Zhou, Paula A Rochon, Richard Platt, Inna Dashevsky, Carly Massino, Cassandra Saphirak, Sybil L Crawford, Jerry H Gurwit. Developing a PRogram to Educate and Sensitize Caregivers to Reduce the Inappropriate Prescription Burden in the Elderly with Alzheimer's Disease (D-PRESCRIBE-AD): Trial protocol and rationale of an open-label pragmatic, prospective randomized controlled trial. PloS one. vol 19. issue 2. 2024-02-13. PMID:38346025. |
developing a program to educate and sensitize caregivers to reduce the inappropriate prescription burden in the elderly with alzheimer's disease (d-prescribe-ad): trial protocol and rationale of an open-label pragmatic, prospective randomized controlled trial. |
2024-02-13 |
2024-02-15 |
Not clear |
| Sube Banerjee, Nicolas Farina, Catherine Henderson, Juliet High, Susan Stirling, Lee Shepstone, Julia Fountain, Clive Ballard, Peter Bentham, Alistair Burns, Chris Fox, Paul Francis, Robert Howard, Martin Knapp, Iracema Leroi, Gill Livingston, Ramin Nilforooshan, Shirley Nurock, John O'Brien, Annabel Price, Alan J Thomas, Ann Marie Swart, Tanya Telling, Naji Tabe. A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial. Health technology assessment (Winchester, England). vol 27. issue 23. 2023-11-06. PMID:37929672. |
a pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with alzheimer's disease and agitated behaviours: the hta-symbad trial. |
2023-11-06 |
2023-11-08 |
Not clear |
| Sascha Dublin, Mikael Anne Greenwood-Hickman, Leah Karliner, Clarissa Hsu, R Yates Coley, Leonardo Colemon, Anna Carrasco, Deborah King, Andrea Grace, Sei J Lee, Judith M E Walsh, Tyler Barrett, Jia Broussard, Umesh Singh, Abisola Idu, Kristine Yaffe, Malaz Boustani, Deborah E Barne. The electronic health record Risk of Alzheimer's and Dementia Assessment Rule (eRADAR) brain health trial: Protocol for an embedded, pragmatic clinical trial of a low-cost dementia detection algorithm. Contemporary clinical trials. 2023-10-20. PMID:37858616. |
the electronic health record risk of alzheimer's and dementia assessment rule (eradar) brain health trial: protocol for an embedded, pragmatic clinical trial of a low-cost dementia detection algorithm. |
2023-10-20 |
2023-11-08 |
Not clear |
| Antonia V Bennett, Kyra O'Brien, Monica Moreno, Kerry Lanigan, Katie Maslow, Carolyn A Malone, Laura C Hanson, Sheryl Zimmerman, Jason Karlawish, Emily A Largent, María P Aranda, Ladson Hinton, Brenda P Nicholson, Louise Phillips, Sam Fazio, Gary Epstein-Lubo. Development of a Lived Experience Panel to inform the design of embedded pragmatic trials of dementia care interventions. Journal of the American Geriatrics Society. 2023-10-03. PMID:37787414. |
the national institute on aging (nia) imbedded pragmatic alzheimer's disease and alzheimer's related dementia clinical trials (impact) collaboratory convened a lived experience panel (lep) to inform the development of research priorities and provide input on conducting embedded pragmatic clinical trials (epcts) of dementia care interventions. |
2023-10-03 |
2023-10-07 |
Not clear |
| Jennifer Gabbard, Tina R Sadarangani, Rupak Datta, Chanee D Fabius, Cameron J Gettel, Natalie F Douglas, Lisa A Juckett, Andrew M Kiselica, Komal Patel Murali, Ellen P McCarthy, Alexia M Torke, Christopher M Callaha. Career development in pragmatic clinical trials to improve care for people living with dementia. Journal of the American Geriatrics Society. 2023-09-22. PMID:37736669. |
national institute on aging (nia) imbedded pragmatic alzheimer's disease and related dementias clinical trials (impact) collaboratory seeks to improve the pipeline of early career researchers qualified to lead epcts by funding career development awards. |
2023-09-22 |
2023-10-07 |
Not clear |
| Stuart G Nicholls, Ahmed A Al-Jaishi, Harrison Niznick, Kelly Carroll, Mohamad Tarek Madani, Katherine D Peak, Leen Madani, Pascale Nevins, Lionel Adisso, Fan Li, Charles Weijer, Susan L Mitchell, Vivian Welch, Ana R Quiñones, Monica Taljaar. Health equity considerations in pragmatic trials in Alzheimer's and dementia disease: Results from a methodological review. Alzheimer's & dementia (Amsterdam, Netherlands). vol 15. issue 1. 2023-02-13. PMID:36777091. |
health equity considerations in pragmatic trials in alzheimer's and dementia disease: results from a methodological review. |
2023-02-13 |
2023-08-14 |
Not clear |
| John N Mafi, Anne M Walling, Chad Villaflores, Sitaram Vangala, Andrea Sorensen, Eric Cheng, Ashley Turner, Zoe Trutner, Grace Cheng, Julia Cave Arbanas, Benjamin Waterman, Suzanne Shu, Noah Goldstein, Catherine Sarkisia. A pragmatic parallel arm randomized-controlled trial of a multi-pronged electronic health record-based clinical decision support tool protocol to reduce low-value antipsychotic prescriptions among older adults with Alzheimer's and related dementias. PloS one. vol 17. issue 12. 2022-12-20. PMID:36538552. |
a pragmatic parallel arm randomized-controlled trial of a multi-pronged electronic health record-based clinical decision support tool protocol to reduce low-value antipsychotic prescriptions among older adults with alzheimer's and related dementias. |
2022-12-20 |
2023-08-14 |
human |
| Julien Dumurgier, Séverine Sabia, Henrik Zetterberg, Charlotte E Teunissen, Bernard Hanseeuw, Adelina Orellana, Susanna Schraen, Audrey Gabelle, Mercè Boada, Thibaud Lebouvier, Eline A J Willemse, Emmanuel Cognat, Agustin Ruiz, Claire Hourregue, Matthieu Lilamand, Elodie Bouaziz-Amar, Jean-Louis Laplanche, Sylvain Lehmann, Florence Pasquier, Philip Scheltens, Kaj Blennow, Archana Singh-Manoux, Claire Paque. A Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging. Neurology. vol 99. issue 7. 2022-08-15. PMID:35970577. |
a pragmatic, data-driven method to determine cutoffs for csf biomarkers of alzheimer disease based on validation against pet imaging. |
2022-08-15 |
2023-08-14 |
Not clear |
| Julien Dumurgier, Séverine Sabia, Henrik Zetterberg, Charlotte Teunissen, Bernard Hanseeuw, Adelina Orellana, Susanna Schraen, Audrey Gabelle, Mercè Boada, Thibaud Lebouvier, Eline A J Willemse, Emmanuel Cognat, Agustin Ruiz, Claire Hourregue, Matthieu Lilamand, Elodie Bouaziz-Amar, Jean-Louis Laplanche, Sylvain Lehmann, Florence Pasquier, Philip Scheltens, Kaj Blennow, Archana Singh-Manoux, Claire Paque. Pragmatic, Data-Driven Method to Determine Cutoffs for CSF Biomarkers of Alzheimer Disease Based on Validation Against PET Imaging. Neurology. 2022-05-26. PMID:35618434. |
pragmatic, data-driven method to determine cutoffs for csf biomarkers of alzheimer disease based on validation against pet imaging. |
2022-05-26 |
2023-08-13 |
Not clear |
| Stuart G Nicholls, Kelly Carroll, Hayden P Nix, Fan Li, Spencer Phillips Hey, Susan L Mitchell, Charles Weijer, Monica Taljaar. Ethical considerations within pragmatic randomized controlled trials in dementia: Results from a literature survey. Alzheimer's & dementia (New York, N. Y.). vol 8. issue 1. 2022-05-05. PMID:35509502. |
this review aims to describe the landscape of pragmatic randomized controlled trials (rcts) in the context of alzheimer's disease (ad) and related dementias with respect to ethical considerations. |
2022-05-05 |
2023-08-13 |
Not clear |
| M Maria Glymour, Vincent Mo. A Large Pragmatic Trial is the Right Solution for Testing Anti-Amyloid Therapies for Alzheimer's Disease. Journal of the American Geriatrics Society. 2022-02-07. PMID:35128639. |
a large pragmatic trial is the right solution for testing anti-amyloid therapies for alzheimer's disease. |
2022-02-07 |
2023-08-13 |
Not clear |
| Monica Taljaard, Fan Li, Bo Qin, Caroline Cui, Leyi Zhang, Stuart G Nicholls, Kelly Carroll, Susan L Mitchel. Methodological challenges in pragmatic trials in Alzheimer's disease and related dementias: Opportunities for improvement. Clinical trials (London, England). 2021-12-07. PMID:34841910. |
methodological challenges in pragmatic trials in alzheimer's disease and related dementias: opportunities for improvement. |
2021-12-07 |
2023-08-13 |
Not clear |
| Monica Taljaard, Fan Li, Bo Qin, Caroline Cui, Leyi Zhang, Stuart G Nicholls, Kelly Carroll, Susan L Mitchel. Methodological challenges in pragmatic trials in Alzheimer's disease and related dementias: Opportunities for improvement. Clinical trials (London, England). 2021-12-07. PMID:34841910. |
we need more pragmatic trials of interventions to improve care and outcomes for people living with alzheimer's disease and related dementias. |
2021-12-07 |
2023-08-13 |
Not clear |
| Simona Luzzi, Sara Baldinelli, Valentina Ranaldi, Chiara Fiori, Andrea Plutino, Fabio M Fringuelli, Mauro Silvestrini, Giosuè Baggio, Carlo Reverber. The neural bases of discourse semantic and pragmatic deficits in patients with frontotemporal dementia and Alzheimer's disease. Cortex; a journal devoted to the study of the nervous system and behavior. vol 128. 2021-06-21. PMID:32353756. |
the neural bases of discourse semantic and pragmatic deficits in patients with frontotemporal dementia and alzheimer's disease. |
2021-06-21 |
2023-08-13 |
Not clear |
| Simona Luzzi, Sara Baldinelli, Valentina Ranaldi, Chiara Fiori, Andrea Plutino, Fabio M Fringuelli, Mauro Silvestrini, Giosuè Baggio, Carlo Reverber. The neural bases of discourse semantic and pragmatic deficits in patients with frontotemporal dementia and Alzheimer's disease. Cortex; a journal devoted to the study of the nervous system and behavior. vol 128. 2021-06-21. PMID:32353756. |
we studied discourse semantic and pragmatic skills in patients with behavioral variant frontotemporal dementia (bvftd) or alzheimer's disease (ad) in comparison to healthy controls. |
2021-06-21 |
2023-08-13 |
Not clear |
| Emily A Largent, Spencer Phillips Hey, Kristin Harkins, Allison K Hoffman, Steven Joffe, Julie C Lima, Alex John London, Jason Karlawis. Ethical and Regulatory Issues for Embedded Pragmatic Trials Involving People Living with Dementia. Journal of the American Geriatrics Society. vol 68 Suppl 2. 2021-06-18. PMID:32589273. |
in this report, the regulation and ethics core of the national institute on aging imbedded pragmatic alzheimer's disease (ad) and ad-related dementias (ad/adrd) clinical trials (impact) collaboratory discusses key ethical and regulatory challenges for epcts in plwd. |
2021-06-18 |
2023-08-13 |
human |
| Julie P W Bynum, David A Dorr, Julie Lima, Ellen P McCarthy, Ellen McCreedy, Richard Platt, V G Vinod Vydiswara. Using Healthcare Data in Embedded Pragmatic Clinical Trials among People Living with Dementia and Their Caregivers: State of the Art. Journal of the American Geriatrics Society. vol 68 Suppl 2. 2021-06-18. PMID:32589274. |
grounded in the objectives of the data and technical core of the newly established national institute on aging imbedded pragmatic alzheimer's disease and ad-related dementias clinical trials collaboratory (impact collaboratory), this article summarizes the state of the art in using existing data sources (eg, medicare claims, electronic health records) in ad/adrd epcts and approaches to integrating them in real-world settings. |
2021-06-18 |
2023-08-13 |
Not clear |
| Jill Harrison, Katie Maslow, Ellen Tambor, Louise Phillips, Lori Frank, Laurie Herndon, Gary Epstein-Lubo. Engaging Stakeholders in the Design and Conduct of Embedded Pragmatic Clinical Trials for Alzheimer's Disease and Alzheimer's Disease-Related Dementias. Journal of the American Geriatrics Society. vol 68 Suppl 2. 2021-06-18. PMID:32589275. |
engaging stakeholders in the design and conduct of embedded pragmatic clinical trials for alzheimer's disease and alzheimer's disease-related dementias. |
2021-06-18 |
2023-08-13 |
Not clear |
| Jill Harrison, Katie Maslow, Ellen Tambor, Louise Phillips, Lori Frank, Laurie Herndon, Gary Epstein-Lubo. Engaging Stakeholders in the Design and Conduct of Embedded Pragmatic Clinical Trials for Alzheimer's Disease and Alzheimer's Disease-Related Dementias. Journal of the American Geriatrics Society. vol 68 Suppl 2. 2021-06-18. PMID:32589275. |
embedded pragmatic clinical trials (epcts) of nondrug interventions for alzheimer's disease and alzheimer's disease-related dementias (ad/adrd) are conducted in real-world clinical settings and designed to generate an evidence base to inform clinical and policy decisions about care for this vulnerable population. |
2021-06-18 |
2023-08-13 |
Not clear |
| Heather G Allore, Keith S Goldfeld, Roee Gutman, Fan Li, Joan K Monin, Monica Taljaard, Thomas G Traviso. Statistical Considerations for Embedded Pragmatic Clinical Trials in People Living with Dementia. Journal of the American Geriatrics Society. vol 68 Suppl 2. 2021-06-18. PMID:32589276. |
the national institute on aging imbedded pragmatic alzheimer's disease (ad) and ad-related dementias clinical trials (impact) collaboratory supports clinical trials of such interventions embedded in healthcare systems. |
2021-06-18 |
2023-08-13 |
Not clear |